John E. Imhoff - 21 Aug 2025 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: GTHP
Reported as of: 21 Aug 2025
Net transaction value: +$30,000
SEC form: 4
Accepted by SEC: 05 Sep 2025, 16:16:44 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 12 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ John E. Imhoff

Key filing fact

John E. Imhoff filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 05 Sep 2025.

Key facts

This page summarizes John E. Imhoff's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Sep 2025, 16:16.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: +$30,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001348439 Primary reporting owner

Imhoff John E

Relationship: Director, 10%+ Owner
Address: 5853 PEACHTREE CORNERS EAST, SUITE B, PEACHTREE CORNERS
Signature: /s/ John E. Imhoff
Signature date: 04 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GTHP transaction

Common Stock

Other

Transaction value
Shares: +104,448
Change %: +0.58%
Price
Shares after: 18,096,828
Date: 21 Aug 2025
Ownership: Direct
Footnotes: F1

GTHP transaction

Preferred Series E Stock

Other

Transaction value
Shares: -300
Change %: -75%
Price
Shares after: 100
Date: 21 Aug 2025
Ownership: Direct
Footnotes: F2

GTHP transaction

Common Stock

Other

Transaction value
Shares: +1,200,000
Change %: +6.6%
Price
Shares after: 19,296,828
Date: 21 Aug 2025
Ownership: Direct
Footnotes: F2

GTHP transaction

Common Stock

Purchase

Transaction value: $30,000
Shares: +166,667
Change %: +0.86%
Price: $0.1800
Shares after: 19,463,495
Date: 29 Aug 2025
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GTHP transaction Derivative

Warrants

Purchase

Transaction value
Shares: +166,667
Change %: +667%
Price
Shares after: 191,667
Date: 29 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 166,667
Exercise price: $0.2500
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.

Footnote F2

On August 21, 2025, Mr. Imhoff converted 300 shares of Series E preferred stock into 1,200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.

Footnote F3

On August 29, 2025, the Company entered into a Securities Purchase Agreement with Dr. Imhoff, pursuant to which the Company agreed to sell, for a total price of $30,000, 166,667 units, each unit consisting of one share of common stock and one warrant to purchase up to 166,667 shares of common stock (the "August Warrants"). The August Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.25 per share.